Molecular Targeting of ERKs/RSK2 Signaling in Cancers.
Sign Up to like & getrecommendations! Published in 2017 at "Current pharmaceutical design"
DOI: 10.2174/1381612823666170714142338
Abstract: Accumulating studies have provided concrete evidence that p90 ribosomal S6 kinase 2 (RSK2) is a key signaling molecule involved in cell proliferation, transformation, and cancer development. RSK2 is known to be an etiological gene of… read more here.
Keywords: molecular targeting; rsk2; targeting erks; rsk2 signaling ... See more keywords